Ariel Investments released its second-quarter 2025 investor letter, highlighting a volatile period in the market. Stocks fell sharply in early April before a strong recovery, with excitement for AI stocks driving U.S. indices to new highs. Ariel Fund returned 6.96% in the quarter, lagging behind some indices but outperforming others.

Core Laboratories Inc. (NYSE: CLB) was highlighted in Ariel Fund’s letter, offering reservoir services to the energy industry. The one-month return was -2.06%, with shares losing 49.62% over the last 52 weeks. On July 18, 2025, CLB stock closed at $11.40 per share, with a market cap of $534.465 million.

Ariel Fund noted Core Laboratories Inc. (NYSE: CLB) traded lower in the quarter due to mixed earnings results. Increased demand for diagnostic services in U.S. markets helped the Production Enhancement segment, but weaker Reservoir Description performance was impacted by seasonality, geopolitical tensions, tariffs, and commodity price volatility. Despite these challenges, the company remains focused on international growth and financial stability.

A drilling rig manned by engineers and oil field workers prepares to explore a new petroleum reservoir.

Read more at Yahoo Finance: Here’s Why Core Laboratories (CLB) Traded Lower in Q2